Cellosaurus logo
expasy logo

Cellosaurus HSJD-DIPG-013 (CVCL_C1MI)

[Text version]
Cell line name HSJD-DIPG-013
Synonyms Hospital Sant Joan de Deu-Diffuse Intrinsic Pontine Glioma-013
Accession CVCL_C1MI
Resource Identification Initiative To cite this cell line use: HSJD-DIPG-013 (RRID:CVCL_C1MI)
Comments Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
Sequence variations
Disease Diffuse intrinsic pontine glioma (NCIt: C94764)
Diffuse intrinsic pontine glioma (ORDO: Orphanet_497188)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Category Cancer cell line
STR profile Source(s): PubMed=34732238

Markers:
AmelogeninX
CSF1PO11,12
D5S81811,12
D7S82010,12
D13S3178,11
D16S53912
D21S1129,34.2
TH017
TPOX8,11
vWA13,18

Run an STR similarity search on this cell line
Publications

PubMed=32229503; DOI=10.1158/1541-7786.MCR-19-0507
Wang Z.-H., Xu C., Diplas B.H., Moure C.J., Chen C.-P.J., Chen L.H., Du C.-Z., Zhu H.-S., Greer P.K., Zhang L.-W., He Y.-P., Waitkus M.S., Yan H.
Targeting mutant PPM1D sensitizes diffuse intrinsic pontine glioma cells to the PARP inhibitor olaparib.
Mol. Cancer Res. 18:968-980(2020)

PubMed=34732238; DOI=10.1186/s40478-021-01270-y; PMCID=PMC8565061
Xu C., Liu H., Pirozzi C.J., Chen L.H., Greer P.K., Diplas B.H., Zhang L.-W., Waitkus M.S., He Y.-P., Yan H.
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist.
Acta Neuropathol. Commun. 9:178.1-178.12(2021)

Cross-references
Cell line databases/resources cancercelllines; CVCL_C1MI
Encyclopedic resources Wikidata; Q114311665
Entry history
Entry creation22-Sep-2022
Last entry update19-Dec-2024
Version number6